Related Experiment Video
Updated: May 9, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS
J S Bert1, M Abdullah, T G Dahle
1Department of Internal Medicine, University of Minnesota Medical School, Minneapolis, USA.
Abstract:
Valvular heart disease is a relatively common finding in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), sometimes necessitating valve surgery. Valve replacement may result in significant early and late morbidity and mortality. Surgical risks are even greater when co-morbid conditions including active SLE and renal involvement are present. This is the first report of the successful use of transcatheter aortic valve replacement (TAVR) for severe critical aortic stenosis in a patient with active SLE, renal failure and APS. TAVR may represent an additional, safer, approach to cardiac valve replacement in appropriately selected patients particularly where surgical risk is high and active disease present.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis III: Medical Management